Chengda Pharmaceuticals Co., Ltd Founded in 1999, Chengda Pharmaceuticals Co., Ltd
We process all cell products in our in-house GMP-certified laboratory and test each preparation for sterility, quality, and viability
The standard approach involves 250 to 500 micrograms per day via subcutaneous injection, with peri-lesional injection as an option for superficially accessible injuries such as Achilles tendinopathy or lateral epicondylitis
Peptide therapy is typically done in cycles to ensure it remains effective
Degree of follicle miniaturization (partially functioning follicles respond better than completely dormant ones)
The optimal dosage for men is between 40 and 50 mcg of IGF1 LR3, while for women, the dosage should remain within the 20 mcg bracket